Literature DB >> 12789674

Delusions of Japanese patients with Alzheimer's disease.

Manabu Ikeda1, Kazue Shigenobu, Ryuji Fukuhara, Kazuhiko Hokoishi, Akihiko Nebu, Naruhiko Maki, Michie Nomura, Kenjiro Komori, Hirotaka Tanabe.   

Abstract

BACKGROUND: Delusions constitute one of the most prominent psychiatric complications in Alzheimer's disease (AD). However, there is little consensus of the prevalence and associated factors for delusions in AD. AIMS: To reveal the characteristics of delusions among Japanese patients with AD.
METHOD: 112 consecutive patients with AD were recruited over a one year period and administered the Neuropsychiatric Inventory (NPI).
RESULTS: Delusions were present in 53 patients (47.3%). Delusions of theft were the most common type of delusion (75.5% of patients with delusions), followed by misidentification delusions and delusions of suspicion. More hallucination, agitation, and female gender were found in the delusions group.
CONCLUSIONS: The authors found a high frequency of delusions, particularly of delusions of theft and suggested that gender was associated with the expression of delusions in Japanese patients with AD. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12789674     DOI: 10.1002/gps.864

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

1.  Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.

Authors:  Winnie Qian; Tom A Schweizer; Nathan W Churchill; Colleen Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; David G Munoz; Joseph J Barfett; Tarek K Rajji; Corinne E Fischer
Journal:  Am J Geriatr Psychiatry       Date:  2018-10-02       Impact factor: 4.105

Review 2.  Understanding the Delusion of Theft.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2018-12

3.  Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer's disease: a voxel-based morphometry study.

Authors:  Shutaro Nakaaki; Junko Sato; Katsuyoshi Torii; Mizuki Oka; Atsushi Negi; Takashi Nakamae; Jin Narumoto; Jun Miyata; Toshi A Furukawa; Masaru Mimura
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-21       Impact factor: 2.570

4.  Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology.

Authors:  Jagan A Pillai; James Bena; Kasia Rothenberg; Bryce Boron; James B Leverenz
Journal:  JAMA Netw Open       Date:  2022-03-01

5.  Case Report: Treatment of Delusions of Theft Based on the Assessment of Photos of Patients' Homes.

Authors:  Daiki Ishimaru; Hideki Kanemoto; Maki Hotta; Yuma Nagata; Yuto Satake; Daiki Taomoto; Manabu Ikeda
Journal:  Front Psychiatry       Date:  2022-03-17       Impact factor: 4.157

6.  Missing data analysis in drug-naïve Alzheimer's disease with behavioral and psychological symptoms.

Authors:  Yong Tae Kwak; YoungSoon Yang; Sang-Gue Park
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

7.  Cognitive neuroscience of delusions in aging.

Authors:  Anna E M Holt; Martin L Albert
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

8.  Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status.

Authors:  Yi Xing; Yi Tang; Jianping Jia
Journal:  Behav Neurol       Date:  2015-10-11       Impact factor: 3.342

Review 9.  Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?

Authors:  Daniele Urso; Valentina Gnoni; Marco Filardi; Giancarlo Logroscino
Journal:  Front Psychiatry       Date:  2022-01-18       Impact factor: 4.157

10.  Impact of agitation in long-term care residents with dementia in the United States.

Authors:  Howard Fillit; Myrlene S Aigbogun; Patrick Gagnon-Sanschagrin; Martin Cloutier; Mikhaïl Davidson; Elizabeth Serra; Annie Guérin; Ross A Baker; Christy R Houle; George Grossberg
Journal:  Int J Geriatr Psychiatry       Date:  2021-08-27       Impact factor: 3.850

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.